Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SpectraScience targets Europe

This article was originally published in Clinica

Executive Summary

San Diego, California-based SpectraScience has arranged a distribution deal to sell its WavSTAT optical biopsy system for gastro-enterologists in Europe. A newly formed southern European organisation, called SpectraScience Endoscopy EU (SSEEU), will distribute the cancer screening device. SSEEU "is a well-financed consortium of individuals with extensive experience in medical device markets", said the company. WavSTAT is FDA approved for detecting colon cancer, and is in clinical trials for the detection of Barrett's oesophagus.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT047797

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel